Charles Schwab’s AbCellera Biologics ABCL Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q2 | – | Sell |
-472,389
| Closed | -$3.56M | – | 3608 |
|
|
2023
Q1 | $3.56M | Buy |
472,389
+6,362
| +1% | +$48K | ﹤0.01% | 2349 |
|
|
2022
Q4 | $4.72M | Buy |
466,027
+9,080
| +2% | +$92K | ﹤0.01% | 2239 |
|
|
2022
Q3 | $4.52M | Sell |
456,947
-343
| -0.1% | -$3.39K | ﹤0.01% | 2262 |
|
|
2022
Q2 | $4.87M | Buy |
+457,290
| New | +$4.87M | ﹤0.01% | 2198 |
|